MassMutual Private Wealth & Trust’s Haemonetics HAE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Sell	45 -13	-22%	-$835	﹤0.01%	1830
2026 Q1	$3.27K	Sell	58 -31	-35%	-$2.02K	﹤0.01%	1827
2025 Q4	$7.13K	Buy	89 +57	+178%	+$3.83K	﹤0.01%	1534
2025 Q3	$1.56K	Buy	32 +11	+52%	+$681	﹤0.01%	2044
2025 Q2	$1.57K	Sell	21 -1	-5%	-$66	﹤0.01%	2019
2025 Q1	$1.4K	Sell	22 -13	-37%	-$884	﹤0.01%	2029
2024 Q4	$2.73K	Buy	35 +20	+133%	+$1.61K	﹤0.01%	1739
2024 Q3	$1.21K	Sell	15 -13	-46%	-$1.05K	﹤0.01%	1807
2024 Q2	$2.32K	Buy	28 +8	+40%	+$704	﹤0.01%	1579
2024 Q1	$1.71K	Buy	20 +8	+67%	+$628	﹤0.01%	1587
2023 Q4	$1.03K	Hold	12	–	–	﹤0.01%	1679
2023 Q3	$1.07K	Hold	12	–	–	﹤0.01%	1672
2023 Q2	$1.02K	Hold	12	–	–	﹤0.01%	1648
2023 Q1	$993	Hold	12	–	–	﹤0.01%	1578
2022 Q4	$1K	Buy	+12	New	+$965	﹤0.01%	1456
2021 Q4	–	Sell	-56	Closed	-$4K	–	1423
2021 Q3	$4K	Buy	+56	New	+$3.53K	﹤0.01%	928
2014 Q2	–	Sell	-300	Closed	-$10K	–	565
2014 Q1	$9.78K	Hold	300	–	–	0.01%	338
2013 Q4	$12.6K	Buy	+300	New	+$12.3K	0.01%	274

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's HAE Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Haemonetics (HAE) stake by 22% in Q2 2026, selling an estimated $835 and leaving 45 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

MassMutual Private Wealth & Trust first reported a position in HAE in Q4 2013 and has held it in 18 quarters since. The position peaked at $12.6K in Q4 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

MassMutual Private Wealth & Trust held 45 shares of Haemonetics worth $3.38K as of Q2 2026.
MassMutual Private Wealth & Trust sold 13 Haemonetics shares in Q2 2026, an estimated $835.
Haemonetics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1830 holding.
MassMutual Private Wealth & Trust first reported a position in Haemonetics in Q4 2013 and has held it in 18 quarters since.
MassMutual Private Wealth & Trust's Haemonetics position peaked at $12.6K in Q4 2013.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.